Sativex sublingual cannabis extract spray regulatory update

GW Pharmaceuticals said Sativex was approved in Spain to treat spasticity due to multiple sclerosis (MS). The company also said it submitted an application under the EU's Mutual Recognition Procedure for Sativex in France, Germany and Italy, with the U.K. acting as the reference member state. Sativex was approved in the U.K. in June (see BioCentury, June 28). ...